TOI Stock Summary and Trading Ideas (Oncology Institute | NASDAQ:TOI)

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.

Oncology Institute trades on the NASDAQ stock market under the symbol TOI.

As of November 27, 2024, TOI stock price was flat at $0.17 with 3,365,796 million shares trading.

TOI has a beta of 0.25, meaning it tends to be less sensitive to market movements. TOI has a correlation of 0.00 to the broad based SPY ETF.

TOI has a market cap of $12.83 million. This is considered a Sub-Micro Cap stock.

Last quarter Oncology Institute reported $100 million in Revenue and -$.18 earnings per share. This fell short of revenue expectation by $-8 million and missed earnings estimates by -$.18.

In the last 3 years, TOI traded as high as $12.66 and as low as $.13.

The top ETF exchange traded funds that TOI belongs to (by Net Assets): VTI, VXF, IWC.

TOI has underperformed the market in the last year with a price return of -91.1% while the SPY ETF gained +33.1%. TOI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -52.8% and -41.4%, respectively, while the SPY returned +7.1% and +0.3%, respectively.

TOI support price is $.15 and resistance is $.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TOI shares will trade within this expected range on the day.